1 / 4

FINANCIAL RESULTS FOR THE QUARTER ENDED MARCH 31 , 2005

GLAXOSMITHKLINE CONSUMER HEALTHCARE LIMITED. FINANCIAL RESULTS FOR THE QUARTER ENDED MARCH 31 , 2005. GLAXOSMITHKLINE CONSUMER HEALTHCARE LIMITED UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED MARCH 31, 2005. (RS. LAKHS). GLAXOSMITHKLINE CONSUMER HEALTHCARE LIMITED

kendis
Download Presentation

FINANCIAL RESULTS FOR THE QUARTER ENDED MARCH 31 , 2005

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. GLAXOSMITHKLINE CONSUMER HEALTHCARE LIMITED FINANCIAL RESULTS FOR THE QUARTER ENDED MARCH 31 , 2005

  2. GLAXOSMITHKLINE CONSUMER HEALTHCARE LIMITED UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED MARCH 31, 2005 (RS. LAKHS)

  3. GLAXOSMITHKLINE CONSUMER HEALTHCARE LIMITED UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED MARCH 31, 2005 NOTES (1)The Company is focussed in the business of Nutritional Healthcare in India. Therefore, there is no reportable segment as per the provisions of Accounting Standard 17 on “Segment Reporting” issued by the Institute of Chartered Accountants of India. (2) There were no pending investor complaints at the beginning of the quarter. The Company received 151 complaints during the quarter. 133 complaints were disposed off and balance 18 complaints were pending at the end of the quarter which has since been resolved. (3)The board of directors, of the Company at their meeting held on December 10, 2004, proposed a buy-back of fully paid equity shares of a face value of Rs.10 each at a price not exceeding Rs. 370 per equity share and for an amount not exceeding Rs.12302.81 lakhs in accordance with the provisions of the Companies Act,1956 and Securities and Exchange Board of India (Buy Back of Securities) Regulations, 1998 which was subsequently approved through Postal Ballot by the shareholders. The offer was closed on 12 April, 2005 which was oversubscribed by 135%.The same does not have a financial impact on the profit of the Company for the quarter ended March 31, 2005. (4) Staff Cost includes an amount of Rs.470 Lakhs towards one-time encashment of accumulated leave balances being a change in leave encashment policy for eligible management personnel. (5) Figures of previous quarter/year have been regrouped wherever necessary, to conform to this quarter’s classification. (6) The above results have been reviewed by the Audit Committee of the Board and approved by the Board of Directors of the company at its meeting held on April 28, 2005. The Limited Review by the Statutory Auditors , as required under Clause 41 of the Listing Agreement has been completed and the related report dated April 28, 2005 has been forwarded to the Stock Exchanges. REGD. OFFICE:PATIALA ROAD, NABHA 147201 (PUNJAB). HEAD OFFICE:DLF PLAZA TOWER, DLF CITY PHASE I, GURGAON - 122002, HARYANA. NABHA APRIL 28, 2005 ON BEHALF OF THE BOARD NICHOLAS J. MASSEY MANAGING DIRECTOR

  4. THANK YOU

More Related